| 000 | 01742 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511200837.0 | ||
| 264 | 0 | _c19900314 | |
| 008 | 199003s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19900201)65:3<422::aid-cncr2820650308>3.0.co;2-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVan Der Gaast, A | |
| 245 | 0 | 0 |
_aChemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas. _h[electronic resource] |
| 260 |
_bCancer _cFeb 1990 |
||
| 300 |
_a422-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDigestive System Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenital Neoplasms, Female _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitomycins _xadministration & dosage |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeoplasms, Unknown Primary _xdrug therapy |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aVerwey, J | |
| 700 | 1 | _aPrins, E | |
| 700 | 1 | _aSplinter, T A | |
| 773 | 0 |
_tCancer _gvol. 65 _gno. 3 _gp. 422-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19900201)65:3<422::aid-cncr2820650308>3.0.co;2-y _zAvailable from publisher's website |
| 999 |
_c1695128 _d1695128 |
||